These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2432166)

  • 1. Host-adaptive antigenic variation in Bunyaviruses.
    James WS; Millican D
    J Gen Virol; 1986 Dec; 67 ( Pt 12)():2803-6. PubMed ID: 2432166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between glycoproteins of the viral envelope of bunyaviruses and antibody-dependent plaque enhancement.
    Millican D; Porterfield JS
    J Gen Virol; 1982 Nov; 63 (Pt 1)():233-6. PubMed ID: 6890986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic analysis of Punta Toro virus and identification of protective determinants with monoclonal antibodies.
    Pifat DY; Osterling MC; Smith JF
    Virology; 1988 Dec; 167(2):442-50. PubMed ID: 2462308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent infection of Aedes albopictus C6/36 cells by Bunyamwera virus.
    Elliott RM; Wilkie ML
    Virology; 1986 Apr; 150(1):21-32. PubMed ID: 3952984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic relationships among Turlock serogroup Bunyaviruses as determined by neutralization tests.
    Calisher CH; Lazuick JS; Wolff KL; Muth DJ
    Acta Virol; 1984 Mar; 28(2):148-51. PubMed ID: 6203387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies to Sindbis virus glycoprotein E1 can neutralize, enhance infectivity, and independently inhibit haemagglutination or haemolysis.
    Chanas AC; Gould EA; Clegg JC; Varma MG
    J Gen Virol; 1982 Jan; 58 Pt 1():37-46. PubMed ID: 7142968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two monoclonal antibodies against La Crosse virus show host-dependent neutralizing activity.
    Grady LJ; Kinch W
    J Gen Virol; 1985 Dec; 66 ( Pt 12)():2773-6. PubMed ID: 4067586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-neutralization tests among Cache Valley virus isolates revealing the existence of multiple subtypes.
    Calisher CH; Sabattini MS; Monath TP; Wolff KL
    Am J Trop Med Hyg; 1988 Aug; 39(2):202-5. PubMed ID: 3407840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examination of the immunological relationships between flaviviruses using yellow fever virus monoclonal antibodies.
    Gould EA; Buckley A; Cammack N; Barrett AD; Clegg JC; Ishak R; Varma MG
    J Gen Virol; 1985 Jul; 66 ( Pt 7)():1369-82. PubMed ID: 2410549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies against La Crosse virus.
    Grady LJ; Srihongse S; Grayson MA; Deibel R
    J Gen Virol; 1983 Aug; 64 (Pt 8)():1699-704. PubMed ID: 6192204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properties and characterization of monoclonal antibodies to Tacaribe virus.
    Howard CR; Lewicki H; Allison L; Salter M; Buchmeier MJ
    J Gen Virol; 1985 Jul; 66 ( Pt 7)():1383-95. PubMed ID: 2410550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epitope mapping of human immunodeficiency virus: a monoclonal approach.
    Folks TM
    J Immunol; 1987 Dec; 139(12):3913-4. PubMed ID: 2447155
    [No Abstract]   [Full Text] [Related]  

  • 13. Na+ and K+ concentration and regulation of protein synthesis in L-A9 and Aedes albopictus cells infected with Marituba virus (Bunyaviridae).
    Frugulhetti IC; Rebello MA
    J Gen Virol; 1989 Dec; 70 ( Pt 12)():3493-9. PubMed ID: 2607344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of domain III neutralizing epitopes on the envelope proteins of West Nile virus strains.
    Li L; Barrett AD; Beasley DW
    Virology; 2005 Apr; 335(1):99-105. PubMed ID: 15823609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alanine scanning of the rabies virus glycoprotein antigenic site III using recombinant rabies virus: implication for post-exposure treatment.
    Papaneri AB; Wirblich C; Marissen WE; Schnell MJ
    Vaccine; 2013 Dec; 31(49):5897-902. PubMed ID: 24120673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies specific for the G1 glycoprotein of La Crosse virus that react with other California serogroup viruses.
    Kingsford L; Boucquey KH
    J Gen Virol; 1990 Mar; 71 ( Pt 3)():523-30. PubMed ID: 2179465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of immunoenzyme assay for detecting antigens of California group virus and Bunyamwera group virus (Bunyavirus, Bunyaviridae) in mosquito pools].
    Bystrova EA; Gromashevskiĭ VL; Selivanov IaM; L'vov SD; Grenkova EP; Skvortsova TM; Molibog EV; Aristova VA; Nikolaeva OV
    Vopr Virusol; 1989; 34(6):744-6. PubMed ID: 2576693
    [No Abstract]   [Full Text] [Related]  

  • 18. Host cell selection of antigenic variants of foot-and-mouth disease virus.
    Bolwell C; Brown AL; Barnett PV; Campbell RO; Clarke BE; Parry NR; Ouldridge EJ; Brown F; Rowlands DJ
    J Gen Virol; 1989 Jan; 70 ( Pt 1)():45-57. PubMed ID: 2471782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human infections with Tensaw virus in south Florida: evidence that Tensaw virus subtypes stimulate the production of antibodies reactive with closely related Bunyamwera serogroup viruses.
    Calisher CH; Lazuick JS; Lieb S; Monath TP; Castro KG
    Am J Trop Med Hyg; 1988 Jul; 39(1):117-22. PubMed ID: 2899978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus.
    Gromowski GD; Barrett AD
    Virology; 2007 Sep; 366(2):349-60. PubMed ID: 17719070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.